| Literature DB >> 10459686 |
H Mashiko1, S Niwa, H Kumashiro, Y Kaneko, S Suzuki, Y Numata, R Horikoshi, Y Watanabe.
Abstract
This was the first dose-finding study of trazodone that was designed to be free of the concomitant use of hypnotics, in which the drug was administered in a single dose for sleep disorders combined with a depressive state. As a result, trazodone at the dosage of 50-100 mg/day improved sleep disorders, particularly at the 100 mg/day dosage. It was confirmed that trazodone improved sleep disorders combined with a depressive state when it was administered in a single dose before bedtime with no concomitant hypnotics.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10459686 DOI: 10.1046/j.1440-1819.1999.00532.x
Source DB: PubMed Journal: Psychiatry Clin Neurosci ISSN: 1323-1316 Impact factor: 5.188